By Christy Santhosh Dec 2 (Reuters) - The U.S. Food and Drug Administration's drug evaluation chief, Richard Pazdur, is set ...

President Trump said his administration could attack accused drug traffickers who traverse Latin America by land "very soon," ...

The US Food and Drug Administration’s longtime oncology chief has filed to retire from the agency just weeks after he was ...

The Trump administration says pharmaceutical companies have agreed to slash the Medicare prices for 15 prescription drugs ...

The Trump administration’s pardon of convicted drug trafficker Juan Orlando Hernández raises questions about its war on ...

As troops gather near Venezuela, the Trump administration can't seem to decide whether we're going to war with drug dealers ...

Top drug regulator Richard Pazdur filed papers to retire from the Food and Drug Administration at the end of this month, but ...

FDA has determined that NRx’s Abbreviated New Drug Application (ANDA) is “substantially complete” and received for review.

Weeks after being named head of CDER, Pazdur has submitted paperwork to step down at the end of the month, exacerbating ...

FDA decision-making may be reduced to a sequence of ‘make-a-deals’ with Trump, his FDA, or even political allies,” experts ...

The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of ...